Home Pharmacovigilance

Pharmacovigilance

VTE, increased risk with chlormadinone and ethinylestradiol

staff -

Big data for pharmacovigilance studies

Caterina Lucchini -
Polypharmacy

Drug interactions deserve deeper attention

Treatment guidelines currently in use are generally based on mono-therapies. The debate is open as for the need to consider also drug interactions, a frequent occurrence in polytherapy regimes
Cristiana Bernini -

Adverse drug reactions: the EU-ADR Alliance project

Cristiana Bernini -

Newsstand

  • NCF International n.2 - 2026 NCF International n.2 - 2026
  • NCF International n.1 - 2026 NCF International n.1 - 2026
  • NCF International n.2 - 2025 NCF International n.2 - 2025
Newsstand
© 2026 Helyx srl a socio unico | Milano: Via Eritrea, 21 – 20157 Tel +39 02 2772 991 (Sede legale) | Roma: Viale dell'Arte, 25 - 00144
PEC helyx.srl@legalmail.it | P.IVA 07106000966 | REA MI - 1935962 | Capitale Sociale: €40.000 i.v. | Società soggetta a direzione e coordinamento di Tecniche Nuove S.p.A.